Blum Holdings Inc. Reports First Quarter 2025 Financial Results
GlobeNewswire· 2025-05-14 20:30
Revenue Growth of 26% Year-over-Year, EBITDA Turns Positive Amid Operating Improvements and Streamlined Cost Structure, Net Loss Reduced by Over 80%DOWNEY, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Blum Holdings, Inc. (OTCQB: BLMH) (the “Company,” “Blüm,” “Blüm Holdings,” “we” or “us”), a California-based publicly traded holding company and cannabis operator, announced its financial results for the first quarter ended March 31, 2025. Key Highlights from First Quarter 2025 Revenue increased 26% to $2.2 millio ...
Himax and Vuzix to Showcase Integrated Industry-Ready AR Display Module at Display Week 2025
GlobeNewswire· 2025-05-14 20:30
TAINAN, Taiwan and ROCHESTER, N.Y., May 14, 2025 (GLOBE NEWSWIRE) -- Vuzix® Corporation (Nasdaq: VUZI), ("Vuzix"), a leading supplier of AI-powered smart glasses, waveguides and Augmented Reality (AR) technologies and Himax Technologies, Inc. (Nasdaq: HIMX) (“Himax”), a leading supplier and fabless manufacturer of display drivers and other semiconductor products, today announced the joint debut of a next-generation AR optical module at Display Week 2025, one of the premier symposiums and exhibitions in the ...
NETSOL Technologies Reports Third Quarter Fiscal 2025 Results
GlobeNewswire· 2025-05-14 20:30
Total net revenues for Q3’25 increased by 13%, reaching $17.5 million, when compared with Q3’24.Total service revenue increased 24% in Q3’25, reaching $9.7 million, when compared with Q3,’24.Total subscription (SaaS and Cloud) and support revenues increased 10% to $7.9 million, compared to $7.1 million in the prior year period.Net profit for Q3’2025 was $1.4 million. ENCINO, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- NETSOL Technologies, Inc. (Nasdaq: NTWK), a global business services and asset finance soluti ...
Landsbankinn hf.: Correction - Covered bond exchange offering results - Published: 2025-05-14 14:04:01 CEST
GlobeNewswire· 2025-05-14 20:25
文章核心观点 Landsbankinn进行了有担保债券交换要约,以预定净价98.520买入系列LBANK CB 25的有担保债券,买入金额为23.4亿冰岛克朗,结算将于2025年5月20日进行 [1] 分组1 - Landsbankinn进行有担保债券交换要约,系列LBANK CB 25持有者可按预定净价98.520出售债券 [1] - 交换要约使公司买入系列LBANK CB 25价值23.4亿冰岛克朗的有担保债券 [1] - 结算日期为2025年5月20日 [1]
Rias A/S - Half-Year Report
GlobeNewswire· 2025-05-14 20:23
Half-Year Report - RIAS A/S Attachment Half-Year report for RIAS signed 2025-05-14 ...
Safe & Green Holdings Corp. Provides Corporate Update
GlobeNewswire· 2025-05-14 20:15
MIAMI, FL, May 14, 2025 (GLOBE NEWSWIRE) -- Safe & Green Holdings Corp. (NASDAQ: SGBX) ("Safe & Green Holdings" or the "Company"), a leading developer, designer, and fabricator of modular structures, today provides an update on its recent transformation, marking a new era of financial strength, operational momentum, and strategic expansion. Backed by $108 million in committed funding, and generating strong market engagement, the Company provides a review of key achievements while embarking on an aggressive ...
Antalpha Announces Pricing of Initial Public Offering
GlobeNewswire· 2025-05-14 20:13
SINGAPORE, May 14, 2025 (GLOBE NEWSWIRE) -- Antalpha Platform Holding Company (“Antalpha” or the “Company”) today announced the pricing of its initial public offering of 3,850,000 ordinary shares at a price to the public of $12.80 per ordinary share. The ordinary shares have been approved for listing and are expected to begin trading on the Nasdaq Global Market on May 14, 2025, under the ticker symbol “ANTA.” The offering is expected to close on May 15, 2025, subject to customary closing conditions. Antalph ...
UPDATE -- Abeona Therapeutics® and Lurie Children's Open First Center for ZEVASKYN™ Gene Therapy to Treat Wounds in Painful Skin Disorder
GlobeNewswire· 2025-05-14 20:07
- ZEVASKYN, the first and only cell-based gene therapy for patients with recessive dystrophic epidermolysis bullosa (RDEB), now commercially available in the U.S. - - Ann & Robert H. Lurie Children's Hospital of Chicago, a top-ranked hospital, is ready to evaluate patients for ZEVASKYN treatment - - Abeona Assist™ comprehensive patient services program in place to offer personalized support for eligible patients and their families throughout ZEVASKYN treatment journey - CLEVELAND and CHICAGO, May 14, 2025 ( ...
IO Biotech Reports First Quarter 2025 Financial Results and Business Highlights
GlobeNewswire· 2025-05-14 20:05
Primary endpoint of pivotal Phase 3 trial (IOB-013/KN-D18) of lead investigational therapeutic cancer vaccine in patients with advanced melanoma still expected to readout in third quarter of 2025Data presented at recent congresses reinforces the potential of the company’s T-Win candidates to reshape the tumor microenvironment and drive more effective anti-tumor responsesCompany recognized as one of the most innovative biotechnology companies in the world by Fast Company Company to participate in TD Cowen’s ...
DeFi Development Corp. Reports First Quarter 2025 Financial Results and Provides Strategic Update on Solana Treasury Activity
GlobeNewswire· 2025-05-14 20:00
BOCA RATON, Fla., May 14, 2025 (GLOBE NEWSWIRE) -- DeFi Development Corp. (Nasdaq: DFDV) (“DeFi Dev Corp” or the “Company”), a public-market vehicle focused on long-term Solana (“SOL”) accumulation, today announced financial results for the first quarter ended March 31, 2025, and provided a strategic update on recent treasury activity. Q1 2025 Financial Highlights: 379% year-over-year improvement in annual recurring revenue related to SaaS businessSaaS revenue of approximately $191,000, up 163% year-over-ye ...